Page last updated: 2024-09-03

6,6'-dicorynomycolyl trehalose and Leishmania Infection

6,6'-dicorynomycolyl trehalose has been researched along with Leishmania Infection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, N; Das, A1
Acquafredda, A; Brandonisio, O; Fasanella, A; Gradoni, L; Mitolo, V; Panaro, MA; Scaltrito, D; Trotta, T1

Trials

1 trial(s) available for 6,6'-dicorynomycolyl trehalose and Leishmania Infection

ArticleYear
Comparison between three adjuvants for a vaccine against canine leishmaniasis: In vitro evaluation of macrophage killing ability.
    Comparative immunology, microbiology and infectious diseases, 2010, Volume: 33, Issue:2

    Topics: Adjuvants, Immunologic; Animals; Antigens, Protozoan; BCG Vaccine; Cell Wall Skeleton; Cord Factors; Dog Diseases; Dogs; Female; Humans; Leishmania infantum; Leishmaniasis; Leishmaniasis Vaccines; Leukocytes, Mononuclear; Lipid A; Macrophages; Male; Time Factors

2010

Other Studies

1 other study(ies) available for 6,6'-dicorynomycolyl trehalose and Leishmania Infection

ArticleYear
Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection.
    PLoS neglected tropical diseases, 2014, Volume: 8, Issue:8

    Topics: Animals; Antigens, Protozoan; Cations; Cord Factors; Cricetinae; Cysteine Proteases; Disease Models, Animal; Drug Delivery Systems; Leishmania donovani; Leishmaniasis; Lipid A; Liposomes; Mesocricetus; Protozoan Vaccines

2014